Literature DB >> 15882069

Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53.

Joseph Markowitz1, Richard R Rustandi, Kristen M Varney, Paul T Wilder, Ryan Udan, Su Ling Wu, William DeW Horrocks, David J Weber.   

Abstract

S100B is a dimeric Ca(2+)-binding protein that undergoes a 90 +/- 3 degrees rotation of helix 3 in the typical EF-hand domain (EF2) upon the addition of calcium. The large reorientation of this helix is a prerequisite for the interaction between each subunit of S100B and target proteins such as the tumor suppressor protein, p53. In this study, Tb(3+) was used as a probe to examine how binding of a 22-residue peptide derived from the C-terminal regulatory domain of p53 affects the rate of Ca(2+) ion dissociation. In competition studies with Tb(3+), the dissociation rates of Ca(2+) (k(off)) from the EF2 domains of S100B in the absence and presence of the p53 peptide was determined to be 60 and 7 s(-)(1), respectively. These data are consistent with a previously reported result, which showed that that target peptide binding to S100B enhances its calcium-binding affinity [Rustandi et al. (1998) Biochemistry 37, 1951-1960]. The corresponding Ca(2+) association rate constants for S100B, k(on), for the EF2 domains in the absence and presence of the p53 peptide are 1.1 x 10(6) and 3.5 x 10(5) M(-)(1) s(-)(1), respectively. These two association rate constants are significantly below the diffusion control ( approximately 10(9) M(-)(1) s(-)(1)) and likely involve both Ca(2+) ion association and a Ca(2+)-dependent structural rearrangement, which is slightly different when the target peptide is present. EF-hand calcium-binding mutants of S100B were engineered at the -Z position (EF-hand 1, E31A; EF-hand 2, E72A; both EF-hands, E31A + E72A) and examined to further understand how specific residues contribute to calcium binding in S100B in the absence and presence of the p53 peptide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882069     DOI: 10.1021/bi050321t

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  35 in total

1.  The calcium-dependent interaction between S100B and the mitochondrial AAA ATPase ATAD3A and the role of this complex in the cytoplasmic processing of ATAD3A.

Authors:  Benoît Gilquin; Brian R Cannon; Arnaud Hubstenberger; Boualem Moulouel; Elin Falk; Nicolas Merle; Nicole Assard; Sylvie Kieffer; Denis Rousseau; Paul T Wilder; David J Weber; Jacques Baudier
Journal:  Mol Cell Biol       Date:  2010-03-29       Impact factor: 4.272

2.  Modulation of sarcoplasmic reticulum Ca2+ release in skeletal muscle expressing ryanodine receptor impaired in regulation by calmodulin and S100A1.

Authors:  Naohiro Yamaguchi; Benjamin L Prosser; Farshid Ghassemi; Le Xu; Daniel A Pasek; Jerry P Eu; Erick O Hernández-Ochoa; Brian R Cannon; Paul T Wilder; Richard M Lovering; David Weber; Werner Melzer; Martin F Schneider; Gerhard Meissner
Journal:  Am J Physiol Cell Physiol       Date:  2011-02-02       Impact factor: 4.249

3.  S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling.

Authors:  Benjamin L Prosser; Nathan T Wright; Erick O Hernãndez-Ochoa; Kristen M Varney; Yewei Liu; Rotimi O Olojo; Danna B Zimmer; David J Weber; Martin F Schneider
Journal:  J Biol Chem       Date:  2007-12-17       Impact factor: 5.157

4.  OptGraft: A computational procedure for transferring a binding site onto an existing protein scaffold.

Authors:  Hossein Fazelinia; Patrick C Cirino; Costas D Maranas
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

5.  Theoretical study on binding of S100B protein.

Authors:  Artur Gieldon; Mattia Mori; Rebecca Del Conte
Journal:  J Mol Model       Date:  2007-08-23       Impact factor: 1.810

Review 6.  The evolution of S100B inhibitors for the treatment of malignant melanoma.

Authors:  Kira G Hartman; Laura E McKnight; Melissa A Liriano; David J Weber
Journal:  Future Med Chem       Date:  2013-01       Impact factor: 3.808

7.  The effects of CapZ peptide (TRTK-12) binding to S100B-Ca2+ as examined by NMR and X-ray crystallography.

Authors:  Thomas H Charpentier; Laura E Thompson; Melissa A Liriano; Kristen M Varney; Paul T Wilder; Edwin Pozharski; Eric A Toth; David J Weber
Journal:  J Mol Biol       Date:  2010-01-04       Impact factor: 5.469

8.  A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics.

Authors:  Sarah C Garrett; Louis Hodgson; Andrew Rybin; Alexei Toutchkine; Klaus M Hahn; David S Lawrence; Anne R Bresnick
Journal:  Biochemistry       Date:  2007-12-23       Impact factor: 3.162

9.  The Calcium-Dependent Interaction of S100B with Its Protein Targets.

Authors:  Danna B Zimmer; David J Weber
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-08-17

10.  Intracellular and Extracellular Effects of S100B in the Cardiovascular Response to Disease.

Authors:  James N Tsoporis; Forough Mohammadzadeh; Thomas G Parker
Journal:  Cardiovasc Psychiatry Neurol       Date:  2010-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.